Samuel So
Academic Appointments
- Professor - Med Center Line, Surgery - General Surgery
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Surgical Oncology 875 Blake Wilbur Dr Clinic B Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 736-1048
- Academic Offices
Personal Information Email Tel (650) 566-8861Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- GI Oncology
- Liver Cancer
- Liver Cancer - Surgery
- Gastrointestinal Cancers - Surgical Oncology
- General Surgery
Administrative Appointments
- Special Adviser on Viral Hepatitis, World Health Organization Western Pacific Region (2011 - present)
- Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies (2006 - 2012)
- Committee on the Prevention and Control of Viral Hepatitis in the United States, Institute of Medicine of the National Academies (2008 - 2010)
- Roundtable on Health Disparity, Institute of Medicine of the National Academies (2008 - 2012)
- Conflict of Interest Committee, Stanford University School of Medicine (2008 - 2011)
- Appointments and Promotion Committee, Stanford University School of Medicine (2007 - 2010)
Honors and Awards
- Outstanding Individual of the Year, Asian American Women Alliance, Santa Clara, California (2011)
- Honor Award for Excellence in Partnering in Global Health, CDC and ATSDR (2010)
- Excellence in Partnering Award-Domestic, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (2010)
- Outstanding American by Choice Award, US Citizenship and Immigration Services (2010)
- Asian American Achievement Award, Organization of Chinese Americans, San Mateo, California (2010)
- 12th Outstanding World Chinese Award, World Chinese Business Foundation, Hong Kong (2010)
Professional Education
| Residency: | University of Minnesota MN (1988) |
| Fellowship: | University of Minnesota School of Medicine MN (1989) |
| Internship: | University of Minnesota MN (1981) |
| Medical Education: | University of Hong Kong, China (1978) |
| Fellowship: | Univ. of Minnesota, Mpls., MN, Multi-organ Transplantation (1989) |
| M.B., B.S.: | Univ. of Hong Kong, Medicine and Surgery (1978) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Team HBV, US&suffix=physician
- Hep B Moms, US&suffix=physician
- Santa Clara Hepatitis B Free Campaign, Santa Clara&suffix=physician
- Asia and Pacific Alliance to Eliminate Viral Hepatitis, Asia&suffix=physician
- An evidence based hepatitis B online training course for healthcare workers in China, Shandong province, China&suffix=physician
- Hepatitis B youth education and vaccination project, Beijing&suffix=physician
Internet Links
Scientific Focus
Current Research Interests
Through a 3 pronged comprehensive program: translational and clinical research, early detection and treatment, and promoting education, awareness and immunization, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Our current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer.
Clinical Trials
- Not Recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
- Not Recruiting Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
- Recruiting Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
- Recruiting Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Publications
- Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol Imaging. 2012 Jul-Aug; (4): 363-72
- Low levels of knowledge and preventive practices regarding vertical hepatitis B transmission among perinatal nurses. J Obstet Gynecol Neonatal Nurs. 2012 Jul-Aug; (4): 494-505
- A model program for hepatitis B vaccination and education of schoolchildren in rural China. Int J Public Health. 2012; (3): 581-8
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012; (17): 6662-7
- Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One. 2011; (2): e16636
- Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces (Providence). 2011; (3): 289-300
Help
Trial Administration